Editor's Corner

Thanks for the feedback

I'd like to thank everyone who took our reader survey. With more than five percent of subscribers responding to the survey, and more coming in, we're getting some valuable feedback on what we're doing right and what we can do better. After just a few months in operation, FierceBioResearcher has more than 6,000 subscribers. That's a great start, but it's just a beginning. If you haven't taken the survey yet, please take a couple of minutes--it's quick!--and let us know more about what we can do here. Don't forget that you can always check out our website and recommend us to others in the biotech research field. - John Carroll

Suggested Articles

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.